Skip to content
National Center for Health Research
  • About Us
    • Key Staff
    • Board of Directors & Other Boards
    • Jobs, Fellowships, Internships & Volunteers
    • Biennial Reports & Newsletters
    • Making a Measurable Difference
    • For The Press
  • Get Involved
    • Events
    • Contribute
    • Let Your Voice Be Heard
  • Health Research 4 U

  • Safe To Play

We’re Speaking Out on Health Issues

NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.

Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years.  Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.

Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks.  Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.

Testimony of Dr. Diana Zuckerman at the Tobacco Products Scientific Advisory Committee Meeting on General Snus

June 26, 2024: NCHR testified at the FDA Advisory Committee about the problems with safety data for General Snus smokeless tobacco and questioned whether they deserve to be labeled as safer than cigarettes.

Read More »

NCHR Testimony at the FDA Listening Session on Advisory Committee Meetings

June 13, 2024: NCHR testified at the FDA listening session on Advisory Committee reform. We expressed concerns with the miscategorization of Consumer Representatives on AdComs and the ability of individuals with prior financial ties to industry to serve on these committees.

Read More »

The Patient, Consumer, and Public Health Coalition Testified at an FDA Listening Session on Advisory Committees

June 13, 2024: The Patient, Consumer, and Public Health coalition testified at the FDA listening session on Advisory Committee reform. We expressed concerns with the miscategorization of Consumer Representatives on AdComs, the inherent conflicts of interests of committee members, and inadequate training provided to appointees.

Read More »

NCHR’s Public Comment on Early Alzheimer’s Disease: Developing Drugs for Treatment; Draft Guidance for Industry

June 10, 2024: NCHR disagrees with assumptions made in FDA guidance aimed at developing drugs for treatment of early stages of Alzheimer’s dementia.

Read More »

NCHR Comment on Proposed Information Collection Request; Comment Request; POTW Influent PFAS Study Data Collection

May 28, 2024: NCHR supports the EPA’s proposed plan to collect data on PFAS contaminants in public water sources but urges EPA to protect public health by expanding the plan to test for many more PFAS chemicals and at more testing plants.

Read More »
Page 10 of 200« First«...89101112...203040...»Last »

What are you looking for?

  • Artificial Turf and Playground Surfaces
  • Medical Care for Adults
    • Getting Past The Hype
    • Alzheimers, Dementia & Other Disabilities
    • Allergies and Autoimmune Diseases
    • Birth Control & Hormone Therapy
    • Breast Implants & Cosmetic Procedures
    • Colds, The Flu & Pain
    • Depression, Stress & Mental Health
    • Diabetes
    • Heart Disease, Cholesterol & Strokes
    • Incontinence, IBS & Constipation
    • Infections, Antibiotics & MRSA
    • Lung Diseases
    • Osteoporosis and Bones & Joint Health
    • Reproductive Health & Breastfeeding
    • Vision
    • Your Medicine Cabinet
  • Child & Teen Health
    • Colds, The Flu & Pain
    • Cosmetic Surgery
    • Diets, Weight & Physical Activity
    • Early Childhood Development
    • Early Puberty & Problems in Sexual Development
    • General Health & Mental Health
    • Hyperactivity & ADHD
    • Health Insurance
    • Infants & Breastfeeding
    • Sports
    • Suicide
    • Toys & Other Children's Products
    • Vaccines
    • Your Medicine Cabinet
  • Violence & Risky Behaviors
    • Avoiding Risky Behaviors in Children
    • Dating Violence & Other Sexual Assault
    • Drinking & Drugs
    • Other Violent Behavior
    • Sex, STDs & Unwanted Pregnancy
    • Smoking
    • Violence in the Home
    • Violence in the Media
  • Preventing Disease & Staying Healthy
    • How Adults Can Prevent Disease
    • Keeping Children & Teens Healthy
    • Reducing Violence
    • Products with Health Risks
    • Survival Guide for Working Moms
  • We’re In The News
    • News That Quotes Us & Our Work
    • Our Interviews, Blogs & OpEds
    • Press Releases
  • Our Research & Training
    • Workshops
    • Our Medical Journal Articles
    • Studies We've Done
  • We’re Speaking Out on Health Issues
    • On Health Policy
    • On Medical Treatments & Products
Best In America: Certified by Independent Charter of America
National Center for Health Research
1001 Connecticut Avenue NW, Suite 1100
Washington, DC 20036
©2025. All rights reserved.
  • Disclaimer
  • Terms of Use
  • Privacy Policy

The content on this site is for informational purposes only and is not intended to provide medical advice, which should be obtained from a medical professional.

Sign Up For Our Monthly Updates!

[ctct form="158" show_title="false"]
  • Make a Donation
  • Contact Us

Follow us

  • Health Research 4 U

  • Safe To Play